MINDI LEMONDS: Open Payments
NPI 1306560818 · SAINT GEORGE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,630 in 133 payments from 28 companies in 2025. Trend: 2023 $1,110 · 2024 $2,605 · 2025 $2,630
Food & beverage: $2,528Education: $103
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $356 |
| Boston Scientific Corporation | 22 | $339 |
| Biogen, Inc. | 12 | $261 |
| Janssen Biotech, Inc. | 6 | $225 |
| PFIZER INC. | 8 | $180 |
| Novartis Pharmaceuticals Corporation | 7 | $176 |
| ARGENX US, INC. | 6 | $146 |
| Alexion Pharmaceuticals, Inc. | 5 | $108 |
| Merz Pharmaceuticals, LLC | 2 | $103 |
| Lundbeck LLC | 4 | $84 |
Products named: General - Pain Management, KESIMPTA, QULIPTA, NURTEC ODT, TYSABRI, VUMERITY, UBRELVY, VYVGART HYTRULO.
Industry payments across UT — which companies pay providers there.
